Management of inflammatory bowel diseases in Eastern Europe

Yazar: Lakatos, L, Lakatos, P L
Baskı/Yayın Bilgisi 2006

Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?

Yazar: Lakatos, L, Lakatos, P L
Baskı/Yayın Bilgisi 2006

A141 CONCORDANCE BETWEEN TUBERCULIN SKIN TEST AND INTERFERON GAMMA RELEASE ASSAY FOR LATENT TUBERCULOSIS SCREENING IN INFLAMMATORY BOWEL DISEASE (META-ANALYSIS).

Yazar: Alrajhi, S, Germain, P, Martel, M, Lakatos, P L, Afif, W
Yayımlandı J Can Assoc Gastroenterol (2018)

Dual mechanism of neuronal ensemble inhibition in primary auditory cortex

Yazar: O’Connell, M.N, Falchier, A, McGinnis, T, Schroeder, C.E, Lakatos, P
Baskı/Yayın Bilgisi 2011

Neuronal Oscillations and Multisensory Interaction in Primary Auditory Cortex

Yazar: Lakatos, P., Chen, C.M., O’Connell, M.N, Mills, A., Schroeder, C.E.
Baskı/Yayın Bilgisi 2007

Multi-Scale Entrainment of Coupled Neuronal Oscillations in Primary Auditory Cortex

Yazar: O’Connell, M. N., Barczak, A., Ross, D., McGinnis, T., Schroeder, C. E., Lakatos, P.
Yayımlandı Front Hum Neurosci (2015)

A174 PATIENT PERSPECTIVES AND EXPECTATIONS IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW

Yazar: Balram, B, Al Khoury, A, Bessissow, T, Afif, W, gonczi, l, abreu, m, Lakatos, P L
Yayımlandı J Can Assoc Gastroenterol (2021)

The leading sense: supramodal control of neurophysiological context by attention

Yazar: Lakatos, P., O’Connell, M.N., Barczak, A., Mills, A., Javitt, D.C., Schroeder, C.E.
Baskı/Yayın Bilgisi 2009

A154 BENEFITS OF IMPLEMENTING A RAPID ACCESS CLINIC IN A HIGH VOLUME INFLAMMATORY BOWEL DISEASE CENTER: ACCESSIBILITY, RESOURCE UTILIZATION AND OUTCOMES

Yazar: Restellini, S, Morin, I, Bessissow, T, Afif, W, Wild, G, Seidman, E G, Bitton, A, Lakatos, P L
Yayımlandı J Can Assoc Gastroenterol (2018)

A232 EFFICACY OF TOFACITINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS: REAL-WORLD DATA

Yazar: Xiao, Y, Lakatos, P L, Bourdages, R, Bitton, A, Afif, W, Kohen, R, Berberi, M, Bessissow, T
Yayımlandı J Can Assoc Gastroenterol (2020)

A153 QUALITY OF CARE AND OUTCOMES IN A TERTIARY HOSPITAL INFLAMMATORY BOWEL (IBD) CENTER: MONITORING AND TREATMENT ALGORITHMS DURING FOLLOW-UP

Yazar: Restellini, S, Gonczi, L, Kurti, Z, Bessissow, T, Afif, W, Wild, G, Kohen, R, Seidman, E G, Bitton, A, Lakatos, P L
Yayımlandı J Can Assoc Gastroenterol (2018)

A155 QUALITY OF CARE IN THE INFLAMMATORY BOWEL DISEASES (IBD) CENTER FROM A TERTIARY REFERRAL HOSPITAL: PATIENT ASSESSMENT STRATEGY AT REFERRAL

Yazar: Restellini, S, Gonczi, L, Kurti, Z, Afif, W, Bessissow, T, Wild, G, Seidman, E G, Kohen, R, Bitton, A, Lakatos, P L
Yayımlandı J Can Assoc Gastroenterol (2018)

A112 HARMONIZATION OF QUALITY OF CARE IN AN IBD CENTER IMPACTS DISEASE OUTCOMES: IMPORTANCE OF STRUCTURE AND PROCESS INDICATORS

Yazar: Reinglas, J, Restellini, S, Gonczi, L, Kurti, Z, Nene, S, Kohen, R, Afif, W, Bessissow, T, Wild, G, Seidman, E G, Lakatos, P
Yayımlandı J Can Assoc Gastroenterol (2019)

A78 IMPACT OF IMPLEMENTING A RAPID ACCESS CLINIC IN A HIGH-VOLUME INFLAMMATORY BOWEL DISEASE CENTER: ACCESSIBILITY, REASOURCE UTILISATION AND OUTCOMES

Yazar: Nene, S, Reinglas, J, Gonczi, L, Kurti, Z, Restellini, S, Kohen, R, Afif, W, Bessissow, T, Wild, G, Seidman, E G, Bitton, A, Lakatos, P
Yayımlandı J Can Assoc Gastroenterol (2019)

A76 HIGH ADHERENCE TO SURVEILLANCE GUIDELINES IN IBD RESULTS IN LOW CRC AND DYSPLASIA RATES, WHILE RATES OF DYSPLASIA AND CANCER ARE LOW BEFORE THE SUGGESTED START OF SURVEILLANCE....

Yazar: Singh, K, Al Khoury, A, Kurti, Z, Gonczi, L, Reinglas, J, Verdon, C, Kohen, R, Bessissow, T, Afif, W, Wild, G, Seidman, E G, Bitton, A, Lakatos, P
Yayımlandı J Can Assoc Gastroenterol (2019)

A134 HIGH ADHERENCE TO SURVEILLANCE GUIDELINES IN IBD RESULTS IN LOW CRC AND DYSPLASIA RATES, WHILE RATES OF DYSPLASIA AND CANCER ARE LOW BEFORE THE SUGGESTED START OF SURVEILLANCE...

Yazar: Singh, K, Al Khoury, A, Kurti, Z, Gonczi, L, Reinglas, J, Verdon, C, Kohen, R, Bessissow, T, Afif, W, Wild, G, Seidman, E G, Bitton, A, Lakatos, P
Yayımlandı J Can Assoc Gastroenterol (2019)

A105 HIGH ADHERENCE TO SURVEILLANCE GUIDELINES IN IBD RESULTS IN LOW CRC AND DYSPLASIA RATES, WHILE RATES OF DYSPLASIA AND CANCER ARE LOW BEFORE THE SUGGESTED START OF SURVEILLANCE...

Yazar: Al Khoury, A, Singh, K, Kurti, Z, Gonczi, L, Reinglas, J, Verdon, C, Kohen, R, Bessissow, T, Afif, W, Wild, G, Seidman, E G, Bitton, A, Lakatos, P
Yayımlandı J Can Assoc Gastroenterol (2019)

A61 FOCUSING ON THE FUTURE: REDUCING BARRIERS AND IMPROVING ACCESS TO IBD SPECIALTY CARE ACROSS CANADA

Yazar: Heisler, C, Mirza, R, Kits, O, Zelinsky, S, Veldhuyzen van Zanten, S, Nguyen, G C, MacMillan, M A, Lakatos, P L, Targownik, L, Fowler, S, Rioux, K P, Jones, J
Yayımlandı J Can Assoc Gastroenterol (2020)

A157 REAL-WORLD TIGHT OBJECTIVE MONITORING WITH ADALIMUMAB LEADS TO EARLIER DOSE OPTIMIZATION AND HIGHER CLINICAL REMISSION RATES AT 12 MONTHS.

Yazar: Xiao, Y, Al Khoury, A, Golovics, P, Kohen, R, Afif, W, Wild, G, Friedman, G, Galiatsatos, P, Hilzenrat, N, Szilagyi, A, Wyse, J, Cohen, A, Bitton, A, Bessissow, T, Lakatos, P L
Yayımlandı J Can Assoc Gastroenterol (2021)

Efficacy and tolerability of once‐monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

Yazar: Reginster, J‐Y, Adami, S, Lakatos, P, Greenwald, M, Stepan, J J, Silverman, S L, Christiansen, C, Rowell, L, Mairon, N, Bonvoisin, B, Drezner, M K, Emkey, R, Felsenberg, D, Cooper, C, Delmas, P D, Miller, P D
Baskı/Yayın Bilgisi 2006